Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Final consideration for iTrack transfer

10 Sep 2020 07:00

RNS Number : 5452Y
Transense Technologies PLC
10 September 2020
 

Transense Technologies plc

 

("Transense" or the "Company")

 

Transense agrees final consideration relating to the transfer of the operational business and trading assets relating to iTrack, to Bridgestone Corporation, Japan ("Bridgestone")

 

Transense Technologies plc, the provider of specialist sensor systems, previously announced that on 24 June 2020 the Company granted an exclusive worldwide licence to ATMS Technology Limited ("ATMS"), a wholly owned subsidiary of Bridgestone, covering all current and future iTrack technology for a period of ten years.

 

In order to capitalise fully on the market potential of the use of the technology, the operational business and trading assets relating to the iTrack system were transferred to ATMS at provisional net asset value of approximately US$1.01m for cash consideration. The amount of the final consideration for the transfer has now been agreed by the parties at US$1.31m, comprising the agreed value of the operational business and trading assets transferred of US$3.26m, less the repayment of working capital loans totalling US$1.95m.

 

The above sums will be reflected in the final audited results for the year ended 30 June 2020 which are planned to be released in late October 2020.

 

 

The Company announces that the website address, at which the information required by AIM Rule 26 can be found, has changed to www.transense.com.

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers, Executive Chairman

Melvyn Segal, Chief Financial Officer

Tel: +44 (0) 1869 238380

finnCap

Ed Frisby, Giles Rolls, Matthew Radley (Corporate Finance)

Tim Redfern, Tim Harper (ECM)

Tel: +44 (0) 20 7220 0500

 

 

About Transense Technologies

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. The directors believe that Transense's Surface Acoustic Wave (SAW) wireless, battery-less sensor systems offer advantages over legacy wireless sensor systems. Transense is targeting the torque, temperature and pressure sensing markets via its SAWSense division. The Translogik division offers a range of tyre testing equipment aimed at fleet managers and tyre service providers. Further details are available at www.transense.com.

 

Transense's shares are admitted to trading on AIM (AIM: TRT).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGGLGLVGGZZ
Date   Source Headline
27th Nov 20245:18 pmRNSResult of AGM
27th Nov 20247:00 amRNSAGM Statement and Trading Update
20th Nov 20243:22 pmRNSHolding(s) in Company
30th Oct 20245:27 pmRNSDirector/PDMR Shareholding - acquisition of shares
21st Oct 20247:00 amRNSPosting of Annual Report & Notice of AGM
10th Oct 202411:05 amRNSDirector/PDMR Shareholding - acquisition of shares
27th Sep 202411:28 amRNSHolding(s) in Company
26th Sep 202410:42 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSFinal Results & Investor Presentation
18th Sep 20247:00 amRNSTransense Selected for £11 Million EV R&D Project
3rd Sep 20247:00 amRNSNotice of Annual Results & Investor Presentation
1st Aug 202410:35 amRNSDirector/PDMR shareholding – acquisition of shares
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSTrading Update
26th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
18th Jun 20247:00 amRNSDirector/PDMR Shareholding – acquisition of shares
30th May 20245:25 pmRNSHolding(s) in Company
30th May 20245:20 pmRNSHolding(s) in Company
24th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSUpcoming Investor & Analyst Events
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.